MedTrace Logo

Imaging Control Study, 3D Echo, MR and RHC.

NCT02198456 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2018-05-23

No results posted yet for this study

Summary

The aim of the study is to intensify the follow up of patients with pulmonary arterial hypertension via modern imaging guided methods in due consideration of the possibilities of three-dimensional echocardiography in order to optimize their specific therapy.

The hypothesis is that the increased use of modern imaging guided tools is essential for the follow up.

Conditions

  • Pulmonary Arterial Hypertension WHO Group I

Sponsors & Collaborators

  • Regina Steringer-Mascherbauer

    lead OTHER

Principal Investigators

  • Regina Steringer-Mascherbauer, MD · Krankenhaus der Elisabethinen Linz GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198456 on ClinicalTrials.gov